Skip to content

King Pharmaceuticals KG AmTrust Reinsurance — Net premiums written

Similar metrics at other companies

Axis Capital Holders logo
AXSReinsurance — Net premiums written
$613.96M-13.0%
SiriusPoint logo
SPNTReinsurance — Net premiums written
$281.85M+2.1%
SiriusPoint logo
SPNTReinsurance — Net written premium
$235.7M-12.2%
Arch Capital Group logo
ACGLReinsurance — Net premiums written
$2.18B-6.0%
Cavco Industries logo
CVCONet premiums written
$17M+0.5%
SiriusPoint logo
SPNTReinsurance — Premiums written, gross
$319.2M-10.0%

Other financials

Income statement

See full
Revenue$10.2M+1,112%
Net income-$7.4M-1,786%
EPS (diluted)-$0.96-586%

Balance sheet

See full
Cash & equivalents$62.2M+1,724%
Total debt$176.7M
Total equity$121.4M+2,773%
Total assets$964.2M

Cash flow

See full
Operating cash flow-$15.1M-1,628%

Valuation

See full
Market cap$70.42M-67.6%
Enterprise value$184.93M-50.0%
P/E1.2×
P/S1.6×-24.3×

Profitability

See full
Net margin131.5%

Returns & leverage

See full
Return on equity90.8%
Debt / equity1.5×

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PremiumsWrittenNet.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's amtrust reinsurance — net premiums written.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is King Pharmaceuticals's amtrust reinsurance — net premiums written?
King Pharmaceuticals (KG) reported amtrust reinsurance — net premiums written of -$308.75K in Q4 2025.
What does amtrust reinsurance — net premiums written mean?
Represents the total premiums generated by the reinsurance segment after deducting premiums ceded to other reinsurers. This metric reflects the volume of business underwritten by the segment before accounting for the timing of revenue recognition.